Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Shares Outstanding (2018 - 2025)

Outset Medical (OM) has disclosed Shares Outstanding for 7 consecutive years, with $21000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding changed N/A to $21000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $21000.0, a N/A change, with the full-year FY2023 number at $3354.0, down 99.99% from a year prior.
  • Shares Outstanding was $17.8 million for Q3 2025 at Outset Medical, up from $21000.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $47.2 million in Q4 2021 to a low of $21000.0 in Q2 2025.
  • A 5-year average of $9.5 million and a median of $49422.5 in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: soared 110477.69% in 2021, then plummeted 100.0% in 2025.
  • Outset Medical's Shares Outstanding stood at $47.2 million in 2021, then plummeted by 99.9% to $48295.0 in 2022, then skyrocketed by 6844.82% to $3.4 million in 2023, then grew by 2.74% to $3.4 million in 2024, then crashed by 99.39% to $21000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Shares Outstanding are $21000.0 (Q3 2025), $17.8 million (Q2 2025), and $21.0 (Q1 2025).